Using CAR T to fight solid tumors
T cells that have been genetically altered to express chimeric antigen receptors (CARs) have demonstrated cancer-fighting activity against hematologic cancers. However, CAR T cell therapy’s potential to treat solid tumors remains a question because of the lack of cell surface antigens specific to cancer cells. A recent study published in the journal Immunity has shown